Does Vitamin D Decrease Risk of Respiratory Infections?
This study by Martineau et al. (BMJ, 2017) aimed to determine if vitamin D supplements reduce the risk of acute respiratory tract infection.
Systematic Review and Meta-Analysis
25 randomized controlled trials were surveyed and 10,933 participants were included. Supplementation with vitamin D was found to reduce the risk of acute respiratory tract infections among all participants (odds ratio 0.88, 95% CI 0.81-0.96, P<0.001). In subgroup analysis, protective effects were observed in individuals who received daily or weekly vitamin D. Protective effects were stronger among those with baseline 25-hydroxyvitamin D levels <25 nmol/L (odds ratio 0.30, 95% CI 0.17 – 0.53) than those with higher levels (odds ratio 0.75, 95% CI 0.60-0.95, P=0.006). Vitamin D did not affect the risk of serious adverse events or death due to any cause. The overall quality of evidence was of high quality. It appears that vitamin D supplementation is safe and protects against acute respiratory infections, particularly in those individuals who are vitamin D deficient.
OBG Project CME requires a modern web browser (Internet Explorer 10+, Mozilla Firefox, Apple Safari, Google Chrome, Microsoft Edge). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, or Real Networks Real One Player.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information
presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Jointly provided by
NOT ENOUGH CME HOURS
It appears you don't have enough CME Hours to take this Post-Test. Feel free to buy additional CME hours or upgrade your current CME subscription plan